Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mirati Therapeutics (NQ: MRTX )

37.98 -0.73 (-1.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,248,052
Open 38.82
Bid (Size) 37.15 (1)
Ask (Size) 41.65 (1)
Prev. Close 38.71
Today's Range 37.82 - 38.91
52wk Range 35.70 - 101.30
Shares Outstanding 51,623,193
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biotech Alert: Searches Spiking For These Stocks Today - Friday, June 2
Various names in the biotech sector are seeing a substantial increase in search activity today. Such names include the likes of Akebia Therapeautics, Corvus Pharmaceuticals, and Mirati Therapeutics. 
Via Talk Markets
Why Dollar Tree Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Beamr Imaging Ltd. (NASDAQ: BMR) shares climbed 211.6% to $6.86 after NVIDIA announced the release of NVENC Video Codec SDK 12.1 showcasing the integration with Beamr CABR. 
Via Benzinga

Performance

YTD
-18.59%
-18.59%
1 Month
-20.71%
-20.71%
3 Month
-3.16%
-3.16%
6 Month
-9.03%
-9.03%
1 Year
-37.21%
-37.21%

More News

Read More
Mirati Therapeutics, Inc. (NASDAQ:MRTX) Investor Alert: Investigation over Possible Breaches of Fiduciary Duties
Via SBWire
Analyst Expectations for Mirati Therapeutics's Future
Via Benzinga
Mirati Therapeutics: Q1 Earnings Insights
Via Benzinga
SVB Leerink Maintains Outperform Rating for Mirati Therapeutics: Here's What You Need To Know
Via Benzinga
Mirati's Sitravatinib Flunks Phase 3 Combo Therapy Study In Type Of Lung Cancer Setting
Via Benzinga
Snowflake, American Eagle, Digital Turbine And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
Via Benzinga
Why Shares of Zai Lab Soared This Week
Via The Motley Fool
Why Mirati Therapeutics Shares Are Nosediving
Via Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
Via Benzinga
SKLZ Stock Alert: Will Skillz Shares Get Delisted?
Via InvestorPlace
Why Are Chinese EV Stocks NIO, XPEV, LI on Watch Today?
Via InvestorPlace
Why Is ProQR (PRQR) Stock Up 83% Today?
Via InvestorPlace
Why Is Mirati Therapeutics (MRTX) Stock Up Today?
Via InvestorPlace
5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More
Via Benzinga
Tesla To $235? Here Are 10 Other Price Target Changes For Wednesday
Via Benzinga
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
Via Benzinga
Another Competitor For Amgen As FDA Approves Mirati Therapeutics' KRAS Inhibitor For Lung Cancer Setting
Via Benzinga
Pinterest, Oracle And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
Nasdaq, S&P 500 Futures Soar Amid Optimistic Expectations Concerning Nov. Inflation: Oracle, Tesla, Pinterest Among Early Movers
Via Benzinga
Mirati Wins FDA Approval For Amgen-Rivaling Cancer Drug As Wild Stock Swing Continues
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.